Product Information
TRETINOIN 0.01% GEL is a generic product labeled by Encube Ethicals, Inc., priced at $2.3019 per GM under NDC 21922005606. Its NADAC has been published 58 times since Aug 27, 2025.
FDA first approved this application on Mar 3, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.1 mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922005606
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TRETINOINApproval Type
Generic (ANDA)
FDA Application
ANDA217588FDA Approved
3/3/2025
TE Code
AB
On Market Since
3/6/2025
Pharmacological Classes
Price Statistics
The NADAC for TRETINOIN 0.01% GEL has been published 58 times since Aug 27, 2025, and over the history we have for it it has declined 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3019 per GM |
|---|---|
| All-time high | $2.4992 (Sep 10, 2025) |
| All-time low | $2.1587 (Feb 18, 2026) |
| 52-week high | $2.4280 |
| 52-week low | $2.1587 |
| Median price | $2.3076 |
| Average price | $2.3031 |
| Largest weekly change | -7.4% (Sep 17, 2025) |
| Weeks tracked | 58 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRETINOIN 0.01% GEL?
The current National Average Drug Acquisition Cost (NADAC) for TRETINOIN 0.01% GEL, manufactured by Encube Ethicals, Inc., is $2.3019 per GM (NDC 21922005606), effective Sep 30, 2026.
How has the price of TRETINOIN 0.01% GEL changed over time?
Over the history we have for it, the NADAC for TRETINOIN 0.01% GEL has declined 7.9%. It has been tracked across 58 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for TRETINOIN 0.01% GEL?
Since Aug 27, 2025, the NADAC for TRETINOIN 0.01% GEL has ranged from a low of $2.1587 (Feb 18, 2026) to a high of $2.4992 (Sep 10, 2025), with a median of $2.3076 per GM.
Are there cheaper alternatives to TRETINOIN 0.01% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RETIN-A 0.01% GEL, is $0.9570 per GM — about 58% below TRETINOIN 0.01% GEL.
Who manufactures TRETINOIN 0.01% GEL?
TRETINOIN 0.01% GEL (NDC 21922005606) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.